Biomarker and pharmacodynamic assays for translational drug development 

Sensitive and reproducible biomarker data

Biomarker and pharmacodynamic (PD) assays are essential tools for understanding how a therapeutic interacts with its biological target and affects downstream pathways. These measurements provide critical insight into target engagement, mechanism of action, and biological response, helping translate preclinical findings into meaningful clinical outcomes.

The use of biomarkers in biotherapeutic development to monitor drug pharmacodynamics, safety, and efficacy has been steadily increasing. Context of use for these assays demands high performance and reliability, which typically points to single-analyte assays over multiplex screening assays to enable straightforward validation and assay robustness.

Gyrolab mouse and human cytokine kits accelerate biotherapeutic development

Why labs choose Gyrolab

Shorter turnaround times
Generate biomarker data in just over one hour instead of waiting most of a day or overnight.

Consistent, reproducible data
Automated workflows reduce operator-dependent variation across batches, studies, and sites. 

Higher throughput with less hands-on time
One operator can process hundreds of data points, freeing up time for other important tasks.

 

Wide dynamic range
Fewer dilutions are needed, even when concentrations vary significantly across samples.

Low sample volume requirements
Nanoliter-scale assays are well-suited for rodent studies, limited sample availability, and longitudinal sampling.

Biomarker assays using Gyroplex® panels
Independent assays with no risk for crosstalk. Straightforward validation of single-analyte assays.

Precision and reproducibility with the Gyrolab automated immunoassay platform

Reliable biomarker and PD data require analytical precision and consistency across studies. The Gyrolab automated immunoassay platform enables high-performance biomarker analysis through its microfluidic CD technology and fully automated workflows.

The platform performs nanoliter-scale immunoassays with precise fluid handling, controlled incubation conditions, and standardized reagent delivery. This results in highly reproducible biomarker measurements, even when analyzing complex biological samples.

Automation also supports efficient assay scaling—from exploratory biomarker studies to large clinical sample sets—while maintaining consistent assay performance.

Gyrolab Cytokine Kits for biomarker and PD studies

Cytokines are key pharmacodynamic biomarkers for many therapeutic modalities, including immunotherapies, biologics, and cell-based treatments. To support reliable cytokine profiling, we utilize Gyrolab Cytokine Kits, designed specifically for the automated Gyrolab platform.

These kits enable:

    • Sensitive and reproducible cytokine quantification
    • Rapid assay setup with standardized reagents
    • Minimal sample consumption through nanoliter-scale assays
    • Consistent performance across studies and laboratories

Gyrolab Cytokine Kits provide a robust solution for monitoring immune responses and pharmacodynamic effects, helping researchers gain deeper insight into therapeutic mechanisms and patient responses.

Need for other assays?

Gyrolab assay protocols are available for additional cytokines and other biomarkers, providing assay conditions to jump-start assay development. In addition, developing your own assay is always possible on the Gyrolab platform's open system.

 

Gyrolab vs ELISA for Biomarker studies 

Time to results

Time to results

Results in just over an hour, compared to several hours or overnight with ELISA.

Hands-on time

Hands-on time

Automated processing reduces manual pipetting and intervention.

Dynamic range

Dynamic range

Fewer dilutions are needed to bring samples into range.

Matrix tolerance

Matrix tolerance

The flow-through format reduces background in complex matrices such as serum.

Sample volume

Sample volume

Nanoliter-scale assays require significantly smaller sample volumes than plate-based methods.

Throughput and runs required

Throughput and runs required

Higher pass rates and faster runtimes reduce repeat burden keeping your project timelines on track.

Validation and data confidence

Gyrolab is used in bioanalytical preclinical and clinical environments where data integrity, traceability, and reproducibility matter. Automated workflows reduce operator-dependent variation, while software support provides audit trails, controlled user access, and structured data handling to support compliance with GLP/GMP expectations.

Assays can be transferred between systems and sites with reproducible results, supporting long-term studies and regulatory submissions without added complexity.

 

Further reading

Scientist woman

Accelerate your biomarker and PD studies

High-quality biomarker and pharmacodynamic data are essential for understanding therapeutic impact and advancing drug candidates efficiently.

Contact us today to learn how our automated biomarker and PD assay solutions can support your drug development program.